A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay

Journal of Visualized Experiments

Volumn , Issue 78, 2013, Pages

  Kuster, Diederik W D ^a   Barefield, David ^a   Govindan, Suresh ^a   Sadayappan, Sakthivel ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Assay; Biochemistry; Biomedical engineering; Cardiac myosin binding protein C; Cardiac troponin I; Cardiology; Cardiovascular disease; Cardiovascular diseases; Cellular biology; Creatine kinase MB; Electrochemiluminescence; ELISA; Genetics; Heart diseases; Immunoassay; Issue 78; Medicine; Molecular biology; Multiplex biomarkers; Myocardial infarction; Myocardial ischemia

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; CREATINE KINASE MB; MYOSIN-BINDING PROTEIN C; TROPONIN I;

BLOOD; CASE CONTROL STUDY; ELECTROCHEMICAL ANALYSIS; HEART INFARCTION; HUMAN; IMMUNOASSAY; LUMINESCENCE; PROCEDURES; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CREATINE KINASE, MB FORM; ELECTROCHEMICAL TECHNIQUES; HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84881534505     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/50786     Document Type: Article

References (15)

1. Thygesen, K., et al. Third universal definition of myocardial infarction. Eur. Heart J. 33, 2551-2567, doi:10.1093/eurheartj/ehs184 (2012).
2. Leng, S.X., et al. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A. Biol. Sci. Med. Sci. 63, 879-884 (2008).
3. Thompson, I., et al. Competitive electrochemiluminescence wash and no-wash immunoassays for detection of serum antibodies to smooth Brucella strains. Clin. Vaccine Immunol. 16, 765-771, doi:10.1128/CVI.00006-09 (2009).
4. Kingsmore, S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug. Discov. 5, 310-320, doi:10.1038/nrd2006 (2006).
5. Altan, Z.M., et al. A long-acting tumor necrosis factor alpha-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis. J. Pharmacol. Exp. Ther. 334, 460-466, doi:10.1124/jpet.110.166488 (2010).
6. Patel, K.D., et al. High sensitivity cytokine detection in acute coronary syndrome reveals up-regulation of interferon gamma and interleukin-10 post myocardial infarction. Clin. Immunol. 133, 251-256, doi:10.1016/j.clim.2009.07.007 (2009).
7. Fu, Q., Zhu, J., & Van Eyk, J.E. Comparison of multiplex immunoassay platforms. Clin. Chem. 56, 314-318, doi:10.1373/clinchem.2009.135087 (2010).
8. Mahajan, V.S. & Jarolim, P. How to interpret elevated cardiac troponin levels. Circulation. 124, 2350-2354, doi:10.1161/CIRCULATIONAHA.111.023697 (2011).
9. Govindan, S., et al. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J. Mol. Cell Cardiol. 52, 154-164, doi:10.1016/j.yjmcc.2011.09.011 (2012).
10. Barefield, D. & Sadayappan, S. Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J. Mol. Cell Cardiol. 48, 866-875, doi:10.1016/j.yjmcc.2009.11.014 (2010).
11. Kuster, D.W., et al. Cardiac myosin binding protein C phosphorylation in cardiac disease. J. Muscle Res. Cell Motil. 33, 43-52, doi:10.1007/s10974-011-9280-7 (2012).
12. Sadayappan, S. & de Tombe, P.P. Cardiac myosin binding protein-C: redefining its structure and function. Biophys. Rev. 4, 93-106, doi:10.1007/s12551-012-0067-x (2012).
13. Sadayappan, S. Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury. Biomark Med. 6, 69-72, doi:10.2217/bmm.11.100 (2012).
14. Fichorova, R.N., et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal. Chem. 80, 4741-4751, doi:10.1021/ac702628q (2008).
15. Malekzadeh, A., et al. Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases. Methods. 56, 508-513, doi:10.1016/j.ymeth.2012.03.017 (2012).